Cargando…
Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation
Anticoagulation and antiplatelet therapies are increasingly used in liver transplant (LT) candidates and recipients due to cardiovascular comorbidities, portal vein thrombosis, or to manage posttransplant complications. The implementation of the new direct-acting oral anticoagulants and the recently...
Autores principales: | Montalvá, Eva, Rodríguez-Perálvarez, Manuel, Blasi, Annabel, Bonanad, Santiago, Gavín, Olga, Hierro, Loreto, Lladó, Laura, Llop, Elba, Pozo-Laderas, Juan Carlos, Colmenero, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128618/ https://www.ncbi.nlm.nih.gov/pubmed/34999660 http://dx.doi.org/10.1097/TP.0000000000004014 |
Ejemplares similares
-
Statement on Antiplatelet Agents and Anticoagulants in Cardiology -
2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019) -
Donation after circulatory death liver transplantation: consensus statements from the Spanish Liver Transplantation Society
por: Hessheimer, Amelia J., et al.
Publicado: (2020) -
It is time for consensus on ‘consensus statements’
por: Blazey, Paul, et al.
Publicado: (2022) -
Anticoagulant Activities of Indobufen, an Antiplatelet Drug
por: Liu, Jia, et al.
Publicado: (2018) -
Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation
por: Yeung, Louise Y Y, et al.
Publicado: (2016)